-+ 0.00%
-+ 0.00%
-+ 0.00%

KALI THERAPEUTICS: IS ALSO ELIGIBLE TO RECEIVE UP TO A TOTAL OF $1.05 BLN IN DEVELOPMENT AND COMMERCIAL MILESTONE PAYMENTS

Reuters·03/23/2026 11:01:35

Please log in to view news